RecruitingPhase 2NCT07516366
Renal
Clear cell renal carcinoma
104
studies recruiting now
as of 7 Sept 2026
533
studies registered in total
as of 7 Sept 2026
2
countries with a recruiting site
as of 7 Sept 2026
8 Apr 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 2NCT03866382
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2NCT07188896
A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)
RecruitingPhase 2NCT06794229
Neoadjuvant Zanzalintinib Plus Nivolumab in Patients With Locally Advanced and/or Inoperable Clear Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis
RecruitingPhase 3NCT06661720
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 104 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Clear cell renal carcinoma study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Clear cell renal carcinoma
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
37 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 3Sunitinib Malate (Sunitinib malate)
Phase 3Axitinib (Inlyta)
Phase 3Sorafenib Tosylate (Nexavar)
Phase 3Pazopanib Hydrochloride (Votrient)
Phase 3Hyaluronidase (Human Recombinant) (Cumulase)
Phase 3Nivolumab (Nivolumab bms)
Phase 2Cadonilimab
Phase 2Tandutinib
+ 29 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).